Debunking CAR T-Cell Myths: The Realities of Patient Selection, Safety, and Access
Charles Turck, PharmD, BCPS, BCCCP
Matthew Lunning, DO, FACP
Liquid Biopsy for Colorectal Cancer Screening: Benefits and Barriers
Brennan Spiegel, MD, MSHS
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Ryan Quigley
David F. McDermott, MD
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Aline Fares, MD
Studying Carboplatin-Paclitaxel + Retifanlimab for Squamous Cell Carcinoma of the Anal Canal
Richard Kim, MD
Uncovering Unmet Needs in Squamous Cell Carcinoma of the Anal Canal Care
Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care
Jorge Nieva, MD
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden
Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Evaluating Dato-DXd for EGFR-Mutated Advanced NSCLC: Data from a Pooled Analysis
Jacob Sands, MD
Elaine Shum, MD
Estelamari Rodriguez, MD, MPH
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
Lisa Newcomb, PhD
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Daniel J. George, MD
ADT Monotherapy for mHSPC: How to Identify the Right Patients
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.